Advertisement
U.S. markets close in 4 hours 53 minutes

Sino Biological,Inc. (301047.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
70.22+0.34 (+0.49%)
At close: 03:04PM CST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in CNY

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/28/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
9.03B11.42B11.07B13.39B12.88B
Enterprise Value
4.33B6.77B5.44B7.42B6.92B
Trailing P/E
40.7850.1652.61N/AN/A
Forward P/E
57.1446.3047.1756.1854.05
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
14.5520.1119.9226.6025.59
Price/Book (mrq)
1.431.831.722.112.03
Enterprise Value/Revenue
6.9836.8440.2347.2647.92
Enterprise Value/EBITDA
16.7884.0685.8879.82327.44

Trading Information

Stock Price History

Beta (5Y Monthly) 0.88
52-Week Change 3-32.54%
S&P500 52-Week Change 329.57%
52 Week High 3123.99
52 Week Low 356.60
50-Day Moving Average 371.50
200-Day Moving Average 382.87

Share Statistics

Avg Vol (3 month) 3570.02k
Avg Vol (10 day) 3539.52k
Shares Outstanding 5129.2M
Implied Shares Outstanding 6129.2M
Float 846.75M
% Held by Insiders 163.82%
% Held by Institutions 19.70%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 42.86%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 32.86%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4116.71%
Dividend Date 3N/A
Ex-Dividend Date 4May 24, 2023
Last Split Factor 21.9:1
Last Split Date 3Mar 30, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sep 30, 2023

Profitability

Profit Margin 37.47%
Operating Margin (ttm)36.14%

Management Effectiveness

Return on Assets (ttm)1.34%
Return on Equity (ttm)3.67%

Income Statement

Revenue (ttm)620.38M
Revenue Per Share (ttm)4.80
Quarterly Revenue Growth (yoy)40.20%
Gross Profit (ttm)N/A
EBITDA 161.15M
Net Income Avi to Common (ttm)232.43M
Diluted EPS (ttm)1.71
Quarterly Earnings Growth (yoy)-16.90%

Balance Sheet

Total Cash (mrq)4.76B
Total Cash Per Share (mrq)36.81
Total Debt (mrq)56.28M
Total Debt/Equity (mrq)0.89%
Current Ratio (mrq)38.88
Book Value Per Share (mrq)48.83

Cash Flow Statement

Operating Cash Flow (ttm)256.12M
Levered Free Cash Flow (ttm)-992.31M